Why the study?
To compare microvascular reactivity between chronic Chagas disease patients and healthy individuals, and evaluate its association with left ventricular ejection fraction in patients.
Is systemic microvascular endothelial dysfunction associated with left ventricular ejection fraction reduction in patients with chronic Chagas disease?
Is systemic microvascular endothelial dysfunction associated with left ventricular ejection fraction reduction in patients with chronic Chagas disease?
Systemic microvascular endothelial dysfunction is associated with reduced left ventricular ejection fraction in patients with chronic Chagas disease, independent of hypertension or diabetes.
Hypothesis-generating for microvascular dysfunction in chronic Chagas disease; leaves open prognostic value and therapeutic relevance.
OBJECTIVE: This study compares microvascular reactivity (MR) in chronic Chagas disease (CD) patients with healthy individuals, matched for sex and age. In addition, we evaluated the association between MR and left ventricular ejection fraction (LVEF) in patients. METHODS: Acetylcholine iontophoresis was performed on the forearm skin, using laser speckle contrast imaging, to evaluate endothelium-dependent vasodilation. Clinical data were obtained from medical records. RESULTS: Thirty-six patients were compared to 25 healthy individuals (controls). Vasodilation was higher in controls, when compared to patients (p < .0001). There was a significant association between LVEF, stratified into quartiles, and MR (p-value for linear trend = .002). In addition, there was no difference in MR between patients with normal LVEF and the control group. In patients, MR was independent of the presence of arterial hypertension or diabetes. CONCLUSIONS: We have shown for the first time that the reduction of MR is associated with a decrease of LVEF in a cohort of chronic CD patients. The results were not affected by comorbidities, such as hypertension or diabetes. The evaluation of systemic endothelial function may be useful to tailor therapeutic and preventive approaches, targeted at systolic left ventricular failure associated with chronic CD cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Kasal et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: